| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | OM Outset Medical, Inc. | Porter Stacey L.89 | Chief People Officer | Sell | 638 | $15.10 | $9,633.80 | -1.0% | -66.5% | -94.5% | |
| Aug 16, 2023 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 2,000 | $17.06 | $34,110.00 | +13.3% | -19.5% | -44.2% | |
| Aug 16, 2023 | AXGN Axogen, Inc. | Neels Guido J48 | Director | Buy | 10,000 | $6.11 | $61,100.00 | +17.2% | -0.5% | +95.0% | |
| Aug 16, 2023 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 668 | $1.18 | $786.04 | -0.2% | - | - | |
| Aug 16, 2023 | SIBN Si-Bone, Inc. | Francis Laura70 | Chief Executive Officer | Sell | 9,012 | $20.96 | $188,899.81 | -0.3% | -17.1% | -33.4% | |
| Aug 16, 2023 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 1,733 | $20.98 | $36,363.03 | -0.6% | -17.1% | -33.4% | |
| Aug 16, 2023 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 3,028 | $15.10 | $45,722.80 | -0.7% | -66.5% | -94.5% | |
| Aug 16, 2023 | OWLT Owlet, Inc. | Scolnick Kathryn R.69 | Chief Financial Officer | Sell | 406 | $4.33 | $1,757.98 | -1.3% | +22.7% | -0.4% | |
| Aug 16, 2023 | OM Outset Medical, Inc. | Williamson Steven S.83 | Chief Commercial Officer | Sell | 635 | $15.10 | $9,588.50 | -0.5% | -66.5% | -94.5% | |
| Aug 16, 2023 | OM Outset Medical, Inc. | Racine Jean-Olivier85 | Chief Technology Officer | Sell | 752 | $15.10 | $11,355.20 | -0.9% | -66.5% | -94.5% | |
| Aug 16, 2023 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 1,565 | $15.10 | $23,631.50 | -1.7% | -66.5% | -94.5% | |
| Aug 16, 2023 | SSKN Strata Skin Sciences, Inc. | 22nw, LP | 10% Owner | Buy | 1,853,056 | $0.55 | $1,023,072.22 | +52.7% | -44.8% | -52.2% | |
| Aug 16, 2023 | CNMD Conmed Corp | Garner Todd W67 | Executive Vice President &CFO | Sell | 1,355 | $112.00 | $151,759.73 | -100% | -3.9% | -39.3% | |
| Aug 16, 2023 | OM Outset Medical, Inc. | Nash Marc83 | SVP Operations And R&D | Sell | 535 | $15.10 | $8,078.50 | -1.2% | -66.5% | -94.5% | |
| Aug 15, 2023 | RMD Resmed Inc | Douglas Robert Andrew71 | President And COO | Sell | 1,500 | $181.01 | $271,515.00 | -0.6% | -22.1% | +21.2% | |
| Aug 15, 2023 | LFWD Lifeward Ltd. | Dan Aryeh | Director | Sell | 9,582 | $0.66 | $6,290.58 | -11.9% | +10.9% | -29.6% | |
| Aug 15, 2023 | ESTA Establishment Labs Holdings Inc. | Lewin Nicholas Sheridan67 | Director | Buy | 400 | $56.13 | $22,452.00 | +4.6% | -60.8% | -26.1% | |
| Aug 15, 2023 | IDXX Idexx Laboratories Inc /de | Ayers Jonathan W63 | Director | Sell | 492 | $0.00 | - | -0.4% | -15.1% | -6.8% | |
| Aug 15, 2023 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 11,671 | $51.30 | $598,677.95 | -15.8% | +3.9% | +47.9% | |
| Aug 15, 2023 | RPID Rapid Micro Biosystems, Inc. | Spignesi Robert G. Jr.53 | President And CEO | Buy | 20,000 | $0.97 | $19,488.00 | +5.6% | 0.0% | -16.5% | |
| Aug 15, 2023 | OSUR Orasure Technologies Inc | Anthony Michele Marie | SVP Finance &CAO | Sell | 1,758 | $6.50 | $11,427.00 | -2.0% | +0.5% | -38.1% | |
| Aug 15, 2023 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 5,675 | $183.20 | $1,039,646.95 | -1.3% | -22.1% | +21.2% | |
| Aug 15, 2023 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 5,000 | $17.93 | $89,640.00 | +25.0% | -29.1% | -49.0% | |
| Aug 15, 2023 | NEPH Nephros Inc | Banks Robert R. Jr.54 | President And CEO | Buy | 2,000 | $1.68 | $3,355.30 | +2,020% | +37.7% | +24.6% | |
| Aug 15, 2023 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 17,087 | $1.51 | $25,801.37 | +0.3% | -7.7% | +22.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.